| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1581923
[patent_doc_number] => 06423754
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-23
[patent_title] => 'Method for treating hypercholesterolemia with polyallylamine polymers'
[patent_app_type] => B1
[patent_app_number] => 08/979096
[patent_app_country] => US
[patent_app_date] => 1997-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4823
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/423/06423754.pdf
[firstpage_image] =>[orig_patent_app_number] => 08979096
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/979096 | Method for treating hypercholesterolemia with polyallylamine polymers | Nov 25, 1997 | Issued |
Array
(
[id] => 3931297
[patent_doc_number] => 05980944
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Simethicone containing pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 8/978358
[patent_app_country] => US
[patent_app_date] => 1997-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 5500
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/980/05980944.pdf
[firstpage_image] =>[orig_patent_app_number] => 978358
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/978358 | Simethicone containing pharmaceutical compositions | Nov 24, 1997 | Issued |
Array
(
[id] => 4229986
[patent_doc_number] => 06074664
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-13
[patent_title] => 'Medicament form for the delivery of collagenase to wounds and process for the preparation thereof'
[patent_app_type] => 1
[patent_app_number] => 8/875723
[patent_app_country] => US
[patent_app_date] => 1997-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4582
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/074/06074664.pdf
[firstpage_image] =>[orig_patent_app_number] => 875723
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/875723 | Medicament form for the delivery of collagenase to wounds and process for the preparation thereof | Nov 16, 1997 | Issued |
Array
(
[id] => 4351109
[patent_doc_number] => 06214889
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Topical application of formate for relief of adverse skin condition for humans'
[patent_app_type] => 1
[patent_app_number] => 8/971413
[patent_app_country] => US
[patent_app_date] => 1997-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 381
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214889.pdf
[firstpage_image] =>[orig_patent_app_number] => 971413
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/971413 | Topical application of formate for relief of adverse skin condition for humans | Nov 16, 1997 | Issued |
Array
(
[id] => 1452626
[patent_doc_number] => 06461640
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Local delivery of fibrinolysis enhancing agents'
[patent_app_type] => B1
[patent_app_number] => 08/967619
[patent_app_country] => US
[patent_app_date] => 1997-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8104
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461640.pdf
[firstpage_image] =>[orig_patent_app_number] => 08967619
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/967619 | Local delivery of fibrinolysis enhancing agents | Nov 11, 1997 | Issued |
Array
(
[id] => 3928087
[patent_doc_number] => 05928666
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Crystalline form of estradiol and pharmaceutical formulations comprising same'
[patent_app_type] => 1
[patent_app_number] => 8/968769
[patent_app_country] => US
[patent_app_date] => 1997-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7279
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928666.pdf
[firstpage_image] =>[orig_patent_app_number] => 968769
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/968769 | Crystalline form of estradiol and pharmaceutical formulations comprising same | Nov 9, 1997 | Issued |
Array
(
[id] => 4300047
[patent_doc_number] => 06326029
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Resorbable extracellular matrix for reconstruction of cartilage tissue'
[patent_app_type] => 1
[patent_app_number] => 8/894517
[patent_app_country] => US
[patent_app_date] => 1997-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2998
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326029.pdf
[firstpage_image] =>[orig_patent_app_number] => 894517
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/894517 | Resorbable extracellular matrix for reconstruction of cartilage tissue | Nov 9, 1997 | Issued |
| 08/894765 | PROCESS FOR THE PREPARATION OF A SOLID PHARMACEUTICAL DOSAGE FORM | Nov 5, 1997 | Abandoned |
Array
(
[id] => 4167827
[patent_doc_number] => 06083497
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers'
[patent_app_type] => 1
[patent_app_number] => 8/964536
[patent_app_country] => US
[patent_app_date] => 1997-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4456
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083497.pdf
[firstpage_image] =>[orig_patent_app_number] => 964536
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/964536 | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers | Nov 4, 1997 | Issued |
Array
(
[id] => 1195771
[patent_doc_number] => 06726905
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-27
[patent_title] => 'Poly (diallylamines)-based phosphate binders'
[patent_app_type] => B1
[patent_app_number] => 08/964498
[patent_app_country] => US
[patent_app_date] => 1997-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13751
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/726/06726905.pdf
[firstpage_image] =>[orig_patent_app_number] => 08964498
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/964498 | Poly (diallylamines)-based phosphate binders | Nov 4, 1997 | Issued |
Array
(
[id] => 4254128
[patent_doc_number] => 06258351
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels'
[patent_app_type] => 1
[patent_app_number] => 8/964972
[patent_app_country] => US
[patent_app_date] => 1997-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5006
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258351.pdf
[firstpage_image] =>[orig_patent_app_number] => 964972
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/964972 | Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels | Nov 4, 1997 | Issued |
| 08/964018 | COSMETIC COMPOSITION IN THE FORM OF A SOFT PASTE AND PROCESS FOR PREPARATION OF SAME | Nov 3, 1997 | Abandoned |
Array
(
[id] => 3929075
[patent_doc_number] => 05972373
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Taste masking pharmaceutical composition for oral administration'
[patent_app_type] => 1
[patent_app_number] => 8/945822
[patent_app_country] => US
[patent_app_date] => 1997-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3343
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972373.pdf
[firstpage_image] =>[orig_patent_app_number] => 945822
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/945822 | Taste masking pharmaceutical composition for oral administration | Oct 30, 1997 | Issued |
Array
(
[id] => 3976395
[patent_doc_number] => 05958453
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility'
[patent_app_type] => 1
[patent_app_number] => 8/960353
[patent_app_country] => US
[patent_app_date] => 1997-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958453.pdf
[firstpage_image] =>[orig_patent_app_number] => 960353
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/960353 | Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility | Oct 28, 1997 | Issued |
Array
(
[id] => 3975394
[patent_doc_number] => 05958388
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Material and method for removing sebum from human skin'
[patent_app_type] => 1
[patent_app_number] => 8/960472
[patent_app_country] => US
[patent_app_date] => 1997-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2383
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958388.pdf
[firstpage_image] =>[orig_patent_app_number] => 960472
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/960472 | Material and method for removing sebum from human skin | Oct 28, 1997 | Issued |
Array
(
[id] => 6874143
[patent_doc_number] => 20030194440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE OF THE HMG-COA REDUCTASE INHIBITOR FLUVASTATIN'
[patent_app_type] => new
[patent_app_number] => 08/945655
[patent_app_country] => US
[patent_app_date] => 1997-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4001
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194440.pdf
[firstpage_image] =>[orig_patent_app_number] => 08945655
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/945655 | PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE OF THE HMG-COA REDUCTASE INHIBITOR FLUVASTATIN | Oct 23, 1997 | Abandoned |
Array
(
[id] => 4003148
[patent_doc_number] => 05962019
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Oral cyclosporin formulations'
[patent_app_type] => 1
[patent_app_number] => 8/956841
[patent_app_country] => US
[patent_app_date] => 1997-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6728
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962019.pdf
[firstpage_image] =>[orig_patent_app_number] => 956841
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/956841 | Oral cyclosporin formulations | Oct 22, 1997 | Issued |
| 08/956572 | IRON-BINDING POLYMERS FOR ORAL ADMINISTRATION | Oct 22, 1997 | Abandoned |
| 08/913056 | MUCOSAL PREPARATION CONTAINING PHYSIOLOGICALLY ACTIVE PEPTIDE | Oct 21, 1997 | Abandoned |
Array
(
[id] => 3931285
[patent_doc_number] => 05980943
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Sustained antiepileptic therapy'
[patent_app_type] => 1
[patent_app_number] => 8/955159
[patent_app_country] => US
[patent_app_date] => 1997-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7825
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/980/05980943.pdf
[firstpage_image] =>[orig_patent_app_number] => 955159
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/955159 | Sustained antiepileptic therapy | Oct 20, 1997 | Issued |